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Abstract
Nasopharyngeal carcinoma (NPC) is etiologically associated with Epstein-Barr virus (EBV) infection. However, the exact role
of EBV in NPC pathogenesis remains elusive. Activation of signal transducer and activator of transcription 3 (STAT3) is
common in human cancers including NPC and plays an important role in the pathogenesis and progression of human
cancers. Interleukin-6 (IL-6), a major inflammatory cytokine, is a potent activator of STAT3. In this study, we report that EBV-
infected immortalized nasopharyngeal epithelial (NPE) cells often acquire an enhanced response to IL-6-induced STAT3
activation to promote their growth and invasive properties. Interestingly, this enhanced IL-6/STAT3 response was mediated
by overexpression of IL-6 receptor (IL-6R). Furthermore, IL-6R overexpression enhanced IL-6-induced STAT3 activation in
uninfected immortalized NPE cells in vitro, and promoted growth and tumorigenicity of EBV-positive NPC cell line (C666-1)
in vivo. Moreover, it is shown for the first time that IL-6R was overexpressed in clinical specimens of NPC. IL-6 expression
could also be strongly detected in the stromal cells of NPC and a higher circulating level of IL-6 was found in the sera of
advance-staged NPC patients compared to the control subjects. Therefore, IL-6R overexpression, coupled with enhanced IL-
6/STAT3 signaling may facilitate the malignant transformation of EBV-infected premalignant NPE cells into cancer cells, and
enhance malignant properties of NPC cells.
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Introduction
Nasopharyngeal carcinoma (NPC) is a distinct type of head of
neck cancer with high prevalence in Southeast Asia [1]. This
malignancy is characterized by Epstein-Barr virus (EBV) infection,
as well as its highly inflammatory stroma and metastatic nature
[2]. EBV is present in virtually all cases of undifferentiated NPC in
endemic regions and has long been postulated to be a crucial
etiologic factor for NPC pathogenesis. Yet to date, the exact role of
EBV in NPC pathogenesis remains unclear [3–5]. The role of
inflammatory cytokines in cancer pathogenesis is well established,
but their effects on EBV-infected premalignant and cancerous
nasopharyngeal epithelia are poorly defined.
Cumulative evidence suggests that multiple factors are involved
in NPC pathogenesis in addition to or in conjunction with EBV
infection [4,6]. STAT3 activation is common in human cancers
including both hematological and solid tumors [7]. Constitutive
activation of STAT3, indicated by increased expression of
phospho-STAT3 (p-STAT3), has been reported in .70% of
NPC specimens [8–10]. Under normal physiological conditions,
STAT3 activation is usually transient and is tightly regulated. In
tumor cells, constitutive activation of STAT3 can be caused by
abnormal and sustained autocrine and/or paracrine signaling
including interleukin-6 (IL-6) signaling [11–13]. IL-6 activates
STAT3 by binding specifically to its cognate receptor on the cell
membrane, i.e. IL-6R. Upon IL-6 binding, the IL-6 receptor
activates the receptor-associated kinases (JAK1, JAK2 and Tyk2),
which subsequently induces phosphorylation and dimerization of
STAT3 (activation of STAT3). Activated STAT3 is then
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translocated into the nucleus to induce target gene transcription
[14,15]. Constitutive STAT3 activation promotes tumor growth
and survival, as well as invasion, epithelial-mesenchymal transition
and angiogenesis [16–18]. A recent study proposed that IL-6-
mediated STAT3 activation may mediate iNOS induction in
NPC, resulting in the formation of mutagenic DNA lesions which
might contribute to its pathogenesis [19].
Despite the emerging biological importance of STAT3 activa-
tion in NPC, the exact mechanism of its activation remains poorly
defined, especially in the context of EBV infection [20]. The L1-
TR promoter of an EBV-encoded oncogene, LMP1, contains
STAT3-responsive element [21]. STAT3 activation could induce
transcription of LMP1 in EBV-infected NPC cells. Moreover,
LMP1 expression upregulates IL-6 production [22,23], which
activates STAT3 signaling to establish a positive feedback loop of
STAT3/LMP1/IL-6/STAT3 activatioin to amplify STAT3
signaling in EBV-infected NPC cells [22].
IL-6-driven STAT3 activation is of particularly significance in
NPC pathogenesis. In vivo, the inflammatory stroma may represent
a potent source of IL-6 to drive STAT3 activation in EBV-infected
nasopharyngeal epithelial (NPE) cells to promote tumorigenesis
and disease progression. Although IL-6 is a key cytokine mediating
STAT3 signaling, the role of IL-6/STAT3 signaling in EBV-
infected pre-malignant NPE cells has not been previously
reported. We have previously established stable EBV infection in
immortalized NPE cells [24,25]. These EBV-infected NPE cell
lines were used in this study to examine the intricate relationship
between STAT3 activation and EBV infection. Interestingly, we
observed for the first time that stable EBV infection in
immortalized NPE cells often resulted in potentiation of their
responses to IL-6-induced STAT3 activation. Furthermore,
STAT3 activation in these EBV-infected NPE cells potentiated
their anchorage independence and invasive properties in vitro. The
mechanisms underlying the enhanced IL-6-induced STAT3
activation signaling in EBV-infected nasopharyngeal cells were




The studies involving human subjects were approved by the
Institutional Review Board of the University of Hong Kong/
Hospital Authority Hong Kong West Cluster, and all subjects
provided written informed consent prior to study participation.
The animal investigations were approved by the Committee on
the USE of Live Animals in Teaching & Research of the
University of Hong Kong. Utmost effort was utilized to prevent
suffering and minimize the numbers of mice required for each
experiment.
Cells and cell culture
The establishment and characterization of immortalized NPE
cell line NP460hTert has been previously described [26].
Establishment of other NPE cell lines including NP550-
cyclinD1-hTert, NP550-CDK4-hTert, NP361-cyclinD1-hTert
will be reported separately. Stable EBV infection was achieved
in these immortalized NPE cells and their culture conditions have
been previously reported [24,25]. EBV infection and cell culture of
NPE cells were performed as previously reported [24]. Human
NPC cell lines CNE2, C666-1, HONE1 were cultured in RPMI-
1640 medium (Sigma, St Louis, MO, USA) containing 10% FBS
at 5% CO2 at 37uC.
Plasmids
The plasmid to express a constitutively active mutant STAT3
(pBabe-STAT3-C), the IL-6 promoter luciferase reporter con-
struct (pGL3-IL-6-Luc), and the m67 luciferase reporter plasmid
used for detection of STAT3 activation (luc-m67) were kindly
provided by Dr. J.F. Bromberg, Department of Medicine,
Memorial Sloan-Kettering Cancer Center, USA [27]. The pUC-
IL-6R used for expression of IL-6R was kindly provided by Dr. R.
Stefan (Institute of Biochemistry, Christian-Albrechts-University,
Germany) [28]. The retroviral expression vector (pBabe-IL-6R)
used to overexpress IL-6R was generated by inserting the IL-6R
fragment from the pUC-IL-6R into the pBabe vector at the SalI
site. The LMP1 expression plasmid (pcDNA 2117) which was used
in a previous study [29] was a generous gift from Dr. D.P. Huang,
Chinese University of Hong Kong.
Western Blotting Analysis
Western blot analyses were carried out as described previously
[26]. Nuclear extracts were prepared from culturing cells using the
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo
Scientific, Rockford, IL, USA) according to manufacturer’s
instructions. The antibodies used to detect IL-6R, cyclin D1 and
b-actin were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The antibodies against STAT3, p-STAT3
(Tyr705) and Bcl-2 were purchased from Cell signaling (Danvers,
MA, USA). The antibodies against c-myc, anti-Flag were
purchased from Sigma. The antibody against LMP-1 was
purchased from Dako (Glostrup, Denmark). The secondary
antibodies used were horseradish peroxidase-linked antibodies
purchased from Invitrogen (Carlsbad, CA, USA). Detection of the
antigen in Western blotting was by ECL Plus chemiluminescence
reagents (GE Healthcare, Buckinghamshire, UK) according to
manufacturer’s instruction.
Electrophoretic-mobility shift assay (EMSA)
EMSA was performed according to manufactor’s instruction
using a commercially available kit for STAT3 activation (Thermo
Scientific). Briefly, whole cell extracts (4 mg protein) prepared from
IL-6-treated and untreated cells were incubated with biotin-
labeled high-affinity serum inducible element (hSIE) duplex
oligonucleotide (GATCCATTTCCCGTAAATC). After gel elec-
trophoresis, the bound STAT3:oligonucleotide was electroblotted
at 350 mA to Biodyne B membrances (nylon) and fixed using a
UV crosslinker. The membranes with the bound oligonucleotide
transferred were blocked, labeled with streptavidin-HPR conju-
gate at 1:1000 concentration, and exposed to ECL Plus
chemiluminescence reagents (GE Healthcare) according to man-
ufacturer’s instruction. Supershifting of the STAT3:oligonucleo-
tide complexes were detected after 30 min preincubation with
anti-STAT3 antibody (Santa Cruz).
Transwell Invasion assay
The Boyden chamber invasion assay was performed using
Transwell chamber from the Milipore Company (6.4 mm in
diameter with 8.0 mm pore size) according to a previously
published method [30]. Cell migration was determined by
averaging the number of cells migrated in ten randomly chosen
microscopic fields at6400 magnification. Data presented are the
mean 6 SD of triplicate wells.
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2000 (Invitrogen) was used for transient
plasmid DNA transfection according to the manufacturer’s
instruction. For measurement of STAT3 transactivating activity
in HONE1 and HONE1-EBV cells, 0.8 mg of m67 luciferase
reporter (luc-m67) plasmid per sample was used. Detection of
STAT3 activation was performed with co-transfection of RcCMV
STAT3-C or control vector with the luciferase reporter plasmid.
For measuring IL-6 gene promoter activity in HONE1 cells,
0.8 mg of pGL3-IL-6-Luc per sample was used. The ratio of firefly
luciferase reporter construct and Renilla used was 200:1. Thirty
six hours after transfection, cells were lysed, and the luciferase
activities were measured using Dual-Luciferase Reporter Kit
(Promega, Madison, WI, USA). The relative luciferase activity was
normalized against the value of Renilla luciferase signal.
Real-time Quantitative PCR
RNA was isolated from samples using TRIzol (Invitrogen).
RNA was reversely transcribed to cDNA using SuperScriptII
reverse transcriptase (Invitrogen) according to previously pub-
lished protocols [26]. The probes and primers were designed using
the Universal Probe Library system (Roche Applied Science,
Mannheim, Germany) according to the manufacturer’s instruc-
tion. The reaction mixture consisted of 0.4 ml forward primer
(10 mM), 0.4 ml backward primer (10 mM), 10 ml LightCycler
master mix, 4 ml autoclaved Milli-Q water, 0.2 ml probe and 5 ml
cDNA. Real time PCR was performed in My IQTM2 Real Time
PCR Detection System (Bio-Rad, Hercules, CA, USA). Gene
specific primers and probes used for the study are listed in Table 1.
The relative levels of mRNA transcripts of the genes examined
were normalized to levels of internal control transcript of
GAPDH.
Anchorage independent growth
Soft-agar colony assay was used to determine the anchorage
independent growth of the EBV-infected and uninfected cells. The
bottom agar (0.6%) was prepared by mixing 6% bacto-agar and
medium at 1:9 ratio. Two ml of upper agar (0.3%) mixed with
16105 cells were then plated on top of the bottom agar. The sizes
of colonies were scored after 3 weeks incubation. Only colonies
.0.2 mm in diameter were counted. Data presented are the mean
6 SD of triplicate wells.
Tumorigenicity assay in nude mice
C666-1 cells (16106 cells) ectopically expressing IL-6R were
harvested and suspended in 50 ml of PBS, and then mixed with an
equal volume of Matrigel
TM
Basement Membrane Matrix (BD
Biosciences, San Jose, CA, USA). The total volume of 100 ml cell
suspension was injected into the flank of 6–8 week old male nude
mice. Once tumor growth was established, tumor sizes were
measured every other day. Tumor volume (mean 6 SD) was
calculated as length6width2/2 [31].
MTT assay
Briefly, 16103 cells per well were seeded in 96-well plate and
incubated overnight. Subsequently, the culture media were
replaced with RPMI medium containing 1% FBS with or without
recombinant human IL-6 and incubated further for the indicated
time points. Thereafter, 20 ml of MTT labeling reagent (5 mg/ml
in PBS; Sigma) was added to each well and incubated for 4 hr at
37uC followed by addition of 200 ml of DMSO to dissolve the
formazan crystals. The absorbance was measured at 570 nm using
a multiplate reader (Merck Eurolab, Dietikon, Switzerland). Each
data point represented the mean 6 SD of three wells per
treatment group.
Immunohistochemistry
Tissue microarray (TMA) containing control and NPC tissue
specimens were obtained from NPC tissue bank established by the
Center for Nasopharyngeal Carcinoma Research (RGC funded
Area of Excellence Theme). Sections for immunohistochemistry
were dewaxed in xylene and rehydrated in graded alcohol.
Endogenous peroxidase activity was blocked by incubating slides
with 3% hydrogen peroxide for 10 min. For antigen retrieval, all
slides were incubated with 10 mmol/L citrate buffer (pH 6.0) for
93uC for 10 min, and then cooled down to room temperature.
After that, the sections were rinsed with PBS and treated with
normal blocking serum (Vector Laboratories, Inc., Burlingame,
CA, USA) for 30 min. Anti-human IL-6 antibody and anti-human
IL-6R antibodies (Santa Cruz) diluted in PBS (1:100) were applied
to the sections and incubated at 4uC overnight. After rinsing, all
sections were further incubated for 1 h with biotin-conjugated
secondary antibody and horseradish peroxidase conjugated
streptavidin followed by a chromogen, diaminobenzidine (Dako).
Counterstaining was performed by hematoxylin before dehydra-
tion and mounting. The negative controls were performed by
adding blocking peptide to replace binding of the primary
antibodies to the antigens.
ELISA for IL-6
The circulating concentrations of IL-6 in the sera of controls
and NPC patients and the supernatants of cell lines were
quantitated using ELISA assay for IL-6 (R&D Systems, Minne-
apolis, MN, USA) according to manufacturer instructions.
Duplicated samples were estimated and the averaged values were
used in the analysis.
Statistical analysis
The data from each experiment were expressed as mean 6
standard derivation (SD). Student’s t test was used to assess the
differences between experimental groups. A p value ,0.05 was
considered as statistically significant throughout this study.
Table 1. Oligonucleotide primers and probes for real-time
PCR.
Gene Oligonucleotide Primer Probe #
LMP1 59 CCCACTCTGCTCTCAAAACC 10
39 GTCCTGTGGGCCATTGTC
IL-6 receptor 59 CACATTCCTGGTTGCTGGA 82
39 CAGCTTCCACGTCTTCTTGA
IL-6 59 GATGAGTACAAAAGTCCTGATCCA 40
39 CTGCAGCCACTGGTTCTGT
GAPDH 59 AGCCACATCGCTCAGACAC 60
39 GCCCAATACGACCAAATCC
doi:10.1371/journal.pone.0062284.t001
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Results
EBV-infection of immortalized NPE cells enhanced their
responses to STAT3 activation induced by IL-6
We have previously reported the establishment of stable EBV
infection in a telomerase-immortalized NPE cell line
(NP460hTert) [24]. When examined for responses to IL-6, we
observed that the EBV-infected NP460 (NP460hTert-EBV) cells
consistently displayed a much higher level of p-STAT3 (Tyr 705)
compared to uninfected NP460hTert cells upon IL-6 exposure
(Figure 1A). We were also able to show a sustained induction of p-
STAT3 at prolonged time points after IL-6 treatment (Figure 1B).
The p-STAT3 could be detected up to 12 hr in EBV-infected cells
(Figure 1B). In control uninfected cells, the level of p-STAT3
already returned to basal level at 0.5 hour (Figure 1A and B). This
observation further supports that IL-6-induced STAT3 activation
is much more potentiated in EBV-infected cells compared to
uninfected ones. We were able to confirm the enhanced activation
of STAT3 to IL-6 treatment in NP460hTert-EBV cells by nuclear
translocation of p-STAT3 (Figure 1C), indicating hyperactivation
of STAT3 by IL-6 in EBV-infected NPE cells, but not the EBV-
negative counterpart. This enhanced activation of STAT3 by IL-6
treatment in NP460hTert-EBV cells was further confirmed by
EMSA (Figure 1D). The specificity of the EMSA for STAT3
activation was confirmed by supershifting the STAT3/DNA
complex after binding to specific antibody to STAT3 (Figure 1E).
The enhancement of IL-6-induced STAT3 activation was also
observed in another immortalized NPE cell line, NP550-cyclinD1-
hTert (recently immortalized by combined action of hTert and
cyclin D1; manuscript in preparation) (Figure 1F). An enhanced
STAT3 activation was also observed in an EBV-infected NPC cell
line, CNE2, despite to a lesser extent (Figure 1G) when compared
to that of immortalized NPE cell lines. The higher level of p-
STAT3 in cancer cells after the IL-6 treatment might account for
a weaker response to enhanced STAT3 activation after EBV
infection. This weaker response in EBV-infected CNE2 was
demonstrated by repeated experiments. Collectively, in the
presence of EBV infection (both EBV-infected NPE and EBV-
infected NPC cells), IL-6 induces hyperactivation of STAT3.
IL-6R overexpression is involved in the potentiation of IL-
6-mediated STAT3 activation in EBV-infected
immortalized NPE cells
Next, we examined the underlying mechanism for such an
enhanced response of EBV-infected NPE cells to IL-6. As IL-6
conveys signaling via the cell surface direct interaction with the IL-
6R, we examined the expression of IL-6R in EBV-infected NPE
cells and the uninfected counterparts. Unexpectedly, overexpres-
sion of IL-6R protein as well as increased levels of IL-6R mRNA
transcripts were detected by Western blotting and real-time PCR,
respectively, in NP460hTert-EBV cells (Figure 2A & 2B).
Interestingly, the protein level of IL-6R was not directly
proportionally to its transcript level. However, the protein level
of a particular gene may not be completely dependent on
transcriptional level. The expression level of a particular protein
may also be regulated by post-translational degradation. In
addition, overexpression of IL-6R by retroviral gene transfer in
NP460hTert cells also conferred the enhanced responsiveness to
IL-6-induced STAT3 activation (Figure 2C). Moreover, the
enhanced STAT3 activation by IL-6 in NP460-EBV cells could
be neutralized by anti-IL-6R antibody treatment (Figure 2D). All
these results indicated that the IL-6R overexpression in
NP460hTert-EBV cells play a key role in mediating the enhanced
responsiveness to STAT3 activation to IL-6 treatment.
We then sought to examine whether IL-6R overexpression was
a direct consequence of EBV infection or the result of progressive
selection of EBV-infected NP460hTert cells overexpressing IL-6R
upon prolonged passages. The expression levels of IL-6R at
different passages of EBV-infected and uninfected NP460hTert
cells were compared. We observed a very moderate increase in IL-
6R expression at the early passage of EBV-infected NP460hTert
cells, and there was a gradual increase in IL-6R expression in
NP460hTert-EBV cells upon prolonged culture (Figure 2E). Note
that such a change of IL-6R levels was not observed in the
uninfected NP460hTert cells over prolonged cultures (Figure 2E).
This strongly indicated that overexpression of IL-6R has selective
growth advantage for EBV-infected NP460hTert cells and was
actively selected in culture. Overexpression of IL-6R was also
detected in three other stably EBV-infected immortalized NPE cell
lines recently established in our laboratory by combined actions of
telomerase with CDK4 or cyclin D1 (NP550-CDK4-hTert-EBV;
NP361-cyclinD1-hTert-EBV; NP550-cyclinD1-hTert-EBV) [25],
but not in uninfected counterparts (NP550-CDK4-hTert; NP361-
cyclinD1-hTert; NP550-cyclinD1-hTert) (Figure 2F). Detailed
characteristics of these newly immortalized NPE cell lines will be
published separately. These observations suggested that overex-
pression of IL-6R has selective growth advantage in EBV-infected
NPE cells and is actively selected over prolonged passages.
Constitutive activation of STAT3 potentiates growth and
malignant properties of EBV-infected cells
We sought to explore some of biological importance of this
active selection of IL-6R expression in EBV-infected NPE cells.
One hypothesis is that EBV infection may induce stress to
immortalized NPE cells [5] and STAT3 activation may overcome
the stress-induced growth arrest in NPE cells after EBV infection
and promote their survival. Activation of STAT3 is known to
activate an array of downstream target events to potentiate growth
and malignant properties of cancer cells [16]. We therefore
examined if STAT3 activation may potentiate growth and
malignant properties of EBV-infected NPE cells. A dominant
active mutant form of STAT3 (STAT3C) was transfected into
EBV-infected and uninfected NP460hTert cells so as to achieve
constitutive activation of STAT3 (Figure 3A). We were able to
observe a moderate increase in expression of c-myc and Bcl-2,
under the constitutive activation of STAT3 in EBV-infected cells
compared to control uninfected cells (Figure 3A). IL-6 treatment
also sustained a longer and stronger expression of cyclin D1 in
EBV-infected cells (Figure 3B). Densitometry was used to analysis
the cyclin D1 levels at 0.5, 1, 2, 4 hour(s) in EBV-infected cells and
uninfected cells after IL-6 treatment. The cyclin D1 level was
upregulated in IL-6-treated EBV-infected cells by 2 folds at 4 hour
time point (Figure 3B). In contrast, the cyclin D1 levels in IL-6-
treated non-infected cells only marginally upregulated at 0.5 hour
and ceased to increase at other time points (Figure 3B). This data
suggests that IL-6 could differentially elevate the expression of
cyclin D1 in EBV-infected cells, but not in non-infected cells.
Interestingly, constitutive activation of STAT3 by STAT3C
expression also enhanced the invasive properties of NP460hTert-
EBV compared with control uninfected NP460hTert cells as
assayed by Matrigel invasion assay (Figure 3C). Furthermore, IL-6
treatment also enhanced the invasive properties of NP460hTert-
EBV cells (Figure 3D). Constitutive activation of STAT3 by
STAT3C expression in NP460hTert-EBV cells also induced
robust anchorage independent growth in soft agar, suggesting a
role of STAT3 activation to promote tumorigenic transformation
of EBV-infected immortalized NPE cells (Figure 3E). The
numbers as well as sizes of the anchorage independent colonies
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Figure 1. Potentiation of IL-6-induced STAT3 activation in EBV-infectedNPE cells. EBV-infected and uninfected NP460hTert cells were treated
with IL-6 at 50 ng/ml for (A) 10, 20 or 30 minutes and for (B) 0.5, 1, 2, 4, 8 or 12 hours. Whole cell lysates were prepared and expression of p-STAT3 (Tyr
705) was analyzed by western blot. Total STAT3 was detected as the control for protein loading. (C) Nuclear extracts were prepared from EBV-infected
and uninfected NP460hTert cells with or without IL-6 treatment (50 ng/ml for 30 minutes) and subjected to Western blot analysis for p-STAT3
expression. Histone 1 was detected as the control for nuclear extract loading. (D) Whole cell protein lysates were prepared following treatment with IL-6
for the indicated time and were then subjected to EMSA analysis using biotin-labeled hSIE probe (containing STAT DNA binding elements). For ‘‘cold’’
competition, extracts were preincubated with unlabeled hSIE probe at 200-fold molar excess for 20 minutes before analysis. (E) The supershift assay was
performed by incubating the extract with anti-STAT3 antibody for 30 minutes before EMSA analysis. The STAT3 specific supershifted complex was
observed which confirmed the specificity of the EMSA for enhanced STAT3 activation in EBV-infected NP460hTert to IL-6 stimulation. (F) NP550-cyclinD1-
hTert and EBV-infected NP550hTert-cyclinD1 were either treated or untreated with IL-6 at a final concentration 50 ng/ml for 30 minutes. The expression
of p-STAT3 (Tyr 705) was analyzed by Western blotting. STAT3 expression was probed as a loading control of proteins. (G) CNE2 and EBV-infected CNE2
cells were either treated or untreated with IL-6 at a final concentration 50 ng/ml for 30 minutes. The expression of p-STAT3 (Tyr 705) was analyzed by
Western blotting. STAT3 expression was probed as a loading control of proteins from different cell populations.
doi:10.1371/journal.pone.0062284.g001
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Figure 2. Upregulation of IL-6R in EBV-infected NPE cells is responsible for the enhanced responsiveness to IL-6-induced STAT3
activation. (A) The expression of IL-6R in EBV-infected and uninfected NP460hTert cells was analyzed by Western blot. Immunoblotting for b-actin
was provided as protein loading control. (B) Total RNA was extracted and the expression levels of IL-6R mRNA in NP460hTert and NP460hTert-EBV
cells were analyzed by quantitative real time RT-PCR. The mRNA levels of IL-6Ra were normalized to cellular GAPDH mRNA. Data were collected from
triplicate separate experiments. * p,0.05. (C) NP460hTert cells were infected with retroviral expression vectors, pBabe-IL-6Ra or pBabe empty vectors.
Stably transduced cells were treated with IL-6 at 50 ng/ml for 30 minutes. Cell lysates were prepared and examined for expression of IL-6Ra and p-
STAT3 (Tyr 705) by Western blot. Immunoblottings for STAT3 and b-actin are shown as controls for protein loading. (D) NP460hTert and NP460hTert-
EBV cells were pre-treated with anti-IL-6R antibody at 5 mg/ml for 30 minutes before IL-6 treatment. The expression of p-STAT3 was analyzed by
Western blot. Immunoblotting for total levels of STAT3 protein is shown as controls for protein loading. (E) After EBV infection, the EBV-infected
NP460hTert cells and its uninfected parental cells were continuously subcultured. Cells lysates were prepared from the cells that had been passaged
for 56, 99 and 133 times (designated as early, middle and late passage). The expression of IL-6R was analyzed by Western blotting. Immunoblotting
for b-actin was included as control for protein loading. (F) The levels of IL-6R expression in cells were detected by Western blot in several paired
uninfected and EBV-infected cell lines, including EBV-infected and non-infected pairs of NP460hTert, NP550-CDK4-hTert, NP361-cyclinD1-hTert,
NP550-cyclinD1-hTert. b-actin expressions were shown as protein loading control.
doi:10.1371/journal.pone.0062284.g002
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Figure 3. Activation of IL-6/IL-6R/STAT3 pathway conferred the malignant properties in EBV-infected NP460hTert cells. (A) c-Myc and
Bcl-2 were induced by STAT3-C expression in NP460hTert and NP460hTert-EBV cells. The FLAG-tagged STAT3-C was transduced and selected in
NP460hTert and NP460hTert-EBV cells. Western blotting analysis revealed the expression of FLAG indicating successful expression of STAT3C.
Expression of c-myc and Bcl-2 was induced in both NP460hTert and NP460hTert-EBV cells after STAT3-C expression. (B) Enhanced expression of cyclin
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in STAT3C-expressing NP460hTert-EBV cells were increased
compared to control cells infected with the empty pBabe vector
(Figure 3E). All these observations showed that STAT3 activation
enhances growth properties in EBV-infected immortalized NPE
cells, which may explain the selection of IL-6R overexpression
phenotype in EBV-infected NPE cells rendering them more
responsive to IL-6-induced STAT3 activation.
IL-6 upregulates LMP1 expression in EBV-infected NPE
and NPC cells
We have previously reported that STAT3 activation could
upregulate LMP1 expression in EBV-infected epithelial cells
[21,22]. Upregulation of LMP1 increases IL-6 production to
enhance STAT3 activation, hence forming a positive feed-back
loop involving IL-6, STAT3 and LMP1 in EBV-infected epithelial
cells (Figure 4A). This positive feedback loop may be involved in
the enhanced growth and malignant properties in EBV-infected
NP460hTert cells after IL-6 treatment or constitutive activation of
STAT3. We confirmed that this positive-feed-back loop exists in
EBV-infected cells. IL-6 treatment of NP460hTert-EBV cells
(EBV-infected NPE cells), C666-1 (EBV-positive NPC cells) and
HONE-EBV (EBV-reinfected NPC cells) all resulted in upregula-
tion of LMP1 transcription (Figure 4B). Furthermore, constitutive
activation of STAT3 in EBV-infected NP460hTert cells upregu-
lated LMP1 transcription (Figure 4C). Increased LMP1 expression
in NP460hTert-EBV cells could also be observed after prolonged
(48 hours) treatment with IL-6 (Figure 4D). We have previously
reported stable expression of LMP1 induced STAT3 activation in
NPC cells, which was confirmed in this study using CNE2 cells, an
NPC cell line (Figure 4E). HONE-1 cells were amenable to gene
transfection and therefore used for further experiments in this part
of study. We have examined and compared STAT3 activity in
EBV-infected or uninfected-HONE-1 cells after transfection with
the dominant active STAT3 mutant (STAT3C) using a luciferase
reporter construct (pLUC-m67) to detect STAT3 activation
(Figure 4F). Transfection of STAT3C stimulated a more robust
activation of STAT3 in EBV-infected HONE-1 cells compared to
uninfected HONE-1 cells (Figure 4F). Furthermore, LMP1
transfection into HONE-1 cells also upregulated the promoter
activity of IL-6 (Figure 4G). These observations confirmed the
existence of the positive feedback loop of STAT3/LMP1/IL-6/
STAT3 in EBV-infected NPE cells, which may contribute to the
enhancement of growth and malignant properties of EBV-infected
cells.
IL-6R overexpression promotes growth of immortalized
NPE cells in vitro and tumorigenic properties of NPC cells
in vivo
Considering the importance of IL-6 signaling in enhancing cell
growth, we postulated that expression of IL-6R, which mediates
IL-6-induced STAT3 activation, should also enhance growth of
immortalized NPE cells and NPC cells. As expected, IL-6
treatment promoted growth in IL-6R-overexpressing NP460hTert
cells (Figure 5A). IL-6 could also enhance the growth of C666-1
cells (an EBV-positive NPC cell line) in vitro (Figure 5B).
We further examined the effects of IL-6R overexpression on the
tumorigenicity of an EBV-positive NPC cell line, C666-1.
Overexpression of IL-6R enhanced the anchorage independent
growth of C666-1 cells by approximately two folds compared to
control C666-1 cells infected with empty vector (Figure 5C). The
sizes of the anchorage independent colonies formed were also
larger in C666-1 overexpressing IL-6R (Figure 5C). In vivo, the IL-
6R-overexpressing C666-1 cells also grew at a faster rate than
control C666-1 cells (Figure 5D). The sizes of tumor xenografts
harvested from IL-6R-expressing C666-1 were on average 64%
larger than the tumor xenografts established from control C666-1
cells (Figure 5D). These observations showed that IL-6R
overexpression enhanced in vivo tumorigenicity of EBV-infected
NPC cells.
Overexpression of IL-6R detected in clinical specimens of
NPC
It has been previously reported that constitutive activation of
STAT3 could be detected in more than 70% of NPC cases [8,9].
We hypothesized that IL-6R expression in NPC cells may be
involved in the activation of STAT3 in vivo. We therefore
examined the expression of IL-6R in NPC tumor biopsies using
a tissue microarray (TMA) containing 7 normal nasopharyngeal
tissues and 45 NPC specimens. IL-6R is overexpressed in NPC
tissues and was detected in 28 out of 45 (62%) NPC specimens
examined, while IL-6R expression was not expressed in any of the
normal nasopharyngeal tissues examined (0 out of 7 cases; 0%)
(Fig 6A). Hence, IL-6R is significantly overexpressed in NPC but
not in normal nasopharyngeal tissues (p,0.05). The IL-6R
expression was mainly localized to NPC cells, but not in normal
NPE cells and lymphoid infiltrates (Fig 6A). However, when we
tried to correlate the IL-6R overexpression with the clinical staging
of NPC (i.e stage I, II, III and IV), the sample size was too small
for statistical analysis and a larger study is required to fully
evaluate the pathological significance of IL-6R in NPC. Since IL-6
is the major inflammatory cytokine that can provoke the IL-6R-
mediated STAT3 activation, we compared the levels of IL-6 in the
sera of NPC patients and healthy subjects using ELISA. A
significant upregulation of the circulating IL-6 was found in the
cancer patients, particularly in the advanced-staged individuals,
than the healthy controls (Fig 6B). We have also detected the IL-6
expression using NPC tissues by immunohistochemical staining.
Strong expression of IL-6 was observed in stromal lymphoid cells
(Fig 6C), suggesting that the stromal infiltrate is a rich source of IL-
6 in NPC. Taken together, an intricate interaction of IL-6
secretion in stromal cells and overexpression of IL-6R in EBV-
infected NPC cells may contribute to the progression of NPC
through enhanced activation of STAT3.
D1 in IL-6-treated NP460hTert-EBV cells was observed compared to control NP460hTert cells. Cells were treated or untreated with IL-6 at a final
concentration 50 ng/ml for the indicated time. In the left panel, expression of cyclin D1 was analyzed by Western blot for protein expression. In the
right panel, densitometry was used to quantify the expression of cyclin D1 with reference to actin. Prolonged expression of cyclin D1 was observed in
IL-6-treated EBV-infected cells but not in the IL-6-treated NP460hTert cells. (C) STAT3-C-expressing NP460hTert and NP460hTert-EBV cells showed
enhanced invasiveness compared with vector control cells. The invasive ability was measured by counting the number of cells that traversed the
Matrigel-coated membrane in 24 hours. Data presented are the mean 6 SD of triplicate wells from triplicate experiments. *, # p,0.05. (D) IL-6
treatment enhanced cell invasion of NP460hTert-EBV cells in vitro. NP460hTert-EBV cells were loaded into the upper invasion chamber with or
without treatment of IL-6 (50 ng/ml). After 24 hours, the cells penetrating into the lower chamber were stained and counted. Data presented are the
mean 6 SD of triplicate wells from triplicate experiments. * p,0.05. (E) pBabe vector control- and STAT3-C-expressing cells (16105) were plated in
soft agar. Three weeks later, pictures of the colonies were taken. Colonies with diameter ($0.2 mm) were counted. The numbers of colonies shown
are the means 6 SD from triplicate results. * p,0.05
doi:10.1371/journal.pone.0062284.g003
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Figure 4. Intricate relationship between IL-6, STAT3 activation and LMP1 in EBV-infected NPE cells. (A) A schematic diagram showing
the positive feedback loop of IL-6 activation of STAT3 and LMP1 expression in EBV-infected cell. (B) NP460hTert-EBV, C666-1 and HONE-EBV cells were
treated with IL-6 for 4 hours. Total RNA were extracted from treated and untreated cells and examined for mRNA expression levels of LMP1 by
quantitative real-time (RT-PCR). Results were normalized to GAPDH. These results were computed from triplicates of individual experiments.
* p,0.05. (C) EBV-infected NP460hTert cells were stably transduced with STAT3-C or control vector. The mRNA expression levels of LMP1 were
analyzed by quantitative RT-PCR. Results were normalized to GAPDH. * p,0.05. (D) LMP1 expression was upregulated in NP460hTert-EBV cells after
treating with IL-6 for 48 hours. (E) PLNSX-LMP1 vector and PLNSX control vector were introduced into CNE2 cells by retroviral infection. Both LMP1
expression and STAT3 phosphorylation in CNE2 cells were confirmed by Western blotting. (F) HONE1 and EBV-infected HONE1 cells were transiently
co-transfected with m67 firefly luciferase reporter construct (luc-m67) in conjunction with a Renilla luciferase vector and STAT3-C plasmid or control
plasmid. Cell lysates were assessed for luciferase activity 36 hours after transfection. Relative luciferase activity was calculated by normalizing the
firefly luciferase activity to Renilla luciferase activity. These results were computed from triplicate separate experiments. * p,0.05 # p,0.05. (G)
HONE1 cells were transiently co-transfected with IL-6 firefly luciferase reporter construct (pGL3-IL-6-Luc) in conjunction with a Renilla luciferase vector
and pcDNA3/2117-LMP1 or control vector. These results were computed from triplicate separate experiments. * p,0.05.
doi:10.1371/journal.pone.0062284.g004
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Figure 5. IL-6R overexpression promotes growth of immortalized NPE cells in vitro and tumorigenic properties of NPC cells in vivo.
(A) pBabe control or pBabe-IL-6Ra expressing NP460hTert cells (16104 per sample) were cultured in the presence of IL-6. Cells were counted at the
indicated time points. Data represent the mean of triple independent experiments6 SD. * p,0.05. The right panel shows the Western blot analysis of
the expression of IL-6R in the NP460-pBabe-IL-6R cells and the control NP460-pBabe cells. (B) Effect of IL-6 on the growth of C666-1 cells. C666-1 cells
were treated with or without IL-6 at 50 ng/ml. The MTT assay was conducted on the indicated time intervals. Each datum point represents the
average of triplicate experiments. * p,0.05. (C) C666-1 cells were transduced with pBabe-IL-6R or pBabe by retroviral gene transfer. Vector- and IL-6R-
expressing C666-1 cells were examined for colony formation in soft agar. Representative images of the soft agar colonies were shown. The number of
colonies presented is mean 6 SD from triplicate results. The difference in the number of soft agar colonies between pBabe- and IL-6R-expressing
C666-1 cells is statistically significant (* p,0.05). (D) pBabe vector control- and IL-6R-expressing C666-1 cells (16106 per mouse) were subcutaneously
injected into nude mice. Tumor size was measured at the indicated time points. Each time point of growth curve was calculated as the mean6 SD of
five tumors per experimental group. The differences in the growth rate in xenografts established from control- and IL-6R-expressing C666-1 cells were
statistically significant after injecting the cells for 21 days (* p,0.05).
doi:10.1371/journal.pone.0062284.g005
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Discussion
EBV infection is closely associated with NPC. However, the
exact role of EBV in NPC pathogenesis remains enigmatic. In
EBV-infected NPC cells, the EBV episomes are readily lost from
the cells upon prolonged culture [5]. We have examined growth
rates in EBV-infected primary and immortalized NPE cells as well
as NPC cells and failed to observe any increase in growth rate of
these cells after EBV infection [24,25]. In fact, many of our EBV-
infected cells exhibited a slower growth rate after infection, which
may reflect a cellular response to stress induced by viral infection
[3]. Hence, EBV infection per se does not appear to confer growth
advantage to infected epithelial cells. This observation is counter-
intuitive as EBV infection is present in most if not all
undifferentiated NPC cells in vivo, clearly indicating an advantage
for NPC cells to retain EBV in vivo. A strong selection pressure
presumably presents in vivo to select EBV-infected NPC cells. The
nature of this selective pressure is poorly defined but is believed to
be pro-survival and anti-apoptotic in nature. The NPC stroma is
rich in inflammatory cells [32]. They may represent potent source
of the inflammatory cytokines which affect the survival and
malignant properties of the EBV-infected premalignant NPE cells
and malignant NPC cells. In this study, we observed IL-6 induced
a much more robust STAT3 activation in EBV-infected NPE cells
than uninfected cells (Fig 1). The STAT3 activation by IL-6 is
well-documented to support growth, survival and metastasis of
human cancer cells [14,16]. In vitro, this enhanced cellular
response to IL-6-induced STAT3 activation may be beneficial to
immortalized NPE cells to overcome the stress-induced growth
inhibition commonly associated with EBV infection [23,25]. In
our immortalized NPE cell models, overexpression of IL-6R was
found to be primarily responsible for the enhanced response to
IL6-activation of STAT3 signaling (Fig 2). Overexpression of IL-
6R was shown to confer growth advantage to premalignant NPE
cells and NPC cells (Fig 5). Our results also showed that STAT3
activation per se enhanced anchorage-independent growth and
Figure 6. Detection of IL-6R and IL-6 in clinical specimens from NPC patients and control subjects. (A) Strong expression of IL-6R was
found in the cancer cells of the NPC tissues but not in the normal nasopharyngeal epithelia. Tissue microarrays (TMAs) of 52 clinical specimens were
analyzed for IL-6R by immunohistochemical staining. Representative image showing the expression of IL-6R in normal nasopharyngeal epithelium
and NPC cancer cells was shown in the left and right panel respectively. A normal nasopharyngeal epithelium is enclosed by the two dotted yellow
lines (in the left image). Underneath the normal nasopharyngeal epithelium are the associated lymphoid cells. A cluster of cancer cells is surrounded
by the red dotted lines (in the right images). NPC is highly infiltrated with stromal cells. (B) The levels of IL-6 in sera measured by ELISA from NPC
patients were significantly higher than the healthy controls (* p,0.05). (C) Representative micrograph showing the expression of IL-6 in the stromal
cells of a NPC tissue. An enlarged image of the enclosed area by black rectangle is shown aside.
doi:10.1371/journal.pone.0062284.g006
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invasive properties of EBV-infected NPE cells (Fig 3E and 3C).
The positive feedback loop of STAT3/LMP1/IL-6/STAT3 may
be involved in the pathogenesis and progression of NPC in patients
(Fig 4).
The role of chronic inflammation in human carcinogenesis has
been long recognized and STAT3 activation is known to be
involved [12]. Infection with H.pylori, which is closely associated
with gastric cancer, also activates STAT3 through its cytotoxin-
associated gene A [33]. STAT3 activation is common in NPC [8–
10]. EBV infection and the expression of viral antigen may also
invoke inflammatory response in NPC which stimulates further
release of inflammatory cytokines to enhance the inflammatory
responses in the host stroma. In this study, we found that the
circulating concentration of IL-6 was significantly upregulated in
the sera of the advance-staged NPC patients than the control
subjects (Fig 6B). Besides, IL-6 expression could be detected in the
stromal cells of NPC (Fig 6C). IL-6R expression may confer a
selective advantage to EBV-infected NPE cells in vivo because of
their enhanced response to IL-6-induced STAT3 activation, and
therefore cells with higher IL-6R expression are favorably selected
EBV-infected NPC cells. This is supported by the observation that
IL-6R overexpression in EBV-positive NPC cells, C666-1,
enhanced its tumorigenic growth in athymic nude mice (Fig 5D).
The positive selection of IL-6R expression in EBV-infected cells
may represent an important process in NPC pathogenesis. We
have also examined the clinical relevance of IL-6R overexpression
in EBV-infected NPC cells in clinical specimens (Fig 6A). IL-6R
overexpression can be detected in the NPC cells (28/45 of cases)
while the expression of IL-6R is relatively low or absent in normal
nasopharyngeal epithelia (Fig 6A). Hence the EBV-infected NPE
cells may co-evolve with the host inflammatory stroma during
NPC pathogenesis to potentiate the growth and malignant
properties of NPC through STAT3 hyperactivation. We could
observe overexpression of IL-6R and p-STAT3 in NPC specimens
using immunocytochemistry. However, p-STAT3 could also be
detected in tissues without IL-6R expression suggesting that
multiple pathways are involved in the activation of STAT3 in
NPC. The contribution of the EBV-encoded LMP1 to the
activation of STAT3 was not evaluated in this study. An earlier
study has examined the relationship of LMP1 expression and
STAT3 activation in nasopharyngeal carcinoma using immuno-
cytochemistry but failed to reveal a positive correlation of LMP1
expression and STAT3 activation [8]. This finding is not
unexpected given the multiple pathways involved in the activation
of STAT3 in NPC. In general, LMP1 expression is infrequently
detected in NPC by immunocytochemical method which may be
related to the low sensitivity of antibody used to detect LMP1
expression in pathological specimens. Using a highly sensitive
nested PCR method, LMP1 transcripts were readily detected in
most cases of LMP1 [3]. A large scale study with well-controlled
NPC specimens collected from different clinical and histopatho-
logical stages and the use of sensitive antibody for LMP1 will be
required to define the relationship of STAT3 activation with
LMP1 and IL-6R expression in EBV-infected NPC and their
impact on the clinico-pathological properties of NPC in patients.
In conclusion, we reported in this study that EBV infection in
NPE cells enhanced their responsiveness to STAT3 activation by
IL-6. Upregulation of IL-6R is involved in the enhanced response
of EBV-infected cells to IL-6. STAT3 activation potentiates
growth and malignant properties in EBV-infected cells, and also
provides a selective advantage for survival of EBV-infected NPC
cells in vivo. An intricate interaction between EBV infection and
stromal inflammatory environment is postulated to be involved in
the pathogenesis of NPC and its progression.
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